Potential Link Between Regular Opioid Use and Increased Dementia Risk
New research associates regular opioid consumption with a higher risk of dementia and brain volume reduction, emphasizing cautious opioid prescribing for chronic pain management.
Recent research published in Alzheimer's & Dementia reveals a significant association between consistent opioid use and a heightened risk of developing dementia, especially vascular dementia. Led by Dr. Sha Feng from the Shenzhen Institute of Advanced Technology and collaborating with experts from Massachusetts Veterans Home and the University of Pennsylvania, the study highlights critical insights into how opioids may influence cognitive health.
Chronic non-cancer pain (CNCP), a condition persisting for over three months unrelated to cancer, saw widespread opioid prescriptions starting in the mid-1990s. This increase has raised concerns over dependence, misuse, and potential neurological impacts. Existing evidence suggests that opioids can alter the brain's endogenous opioid system and impair regions such as the hippocampus, which are vital for cognitive function.
The study analyzed data from 197,673 UK Biobank participants aged between 37 and 73 years over an average follow-up period of nearly 14 years. Employing advanced statistical models to control for confounding factors, researchers found that individuals who regularly used opioids faced a 20% higher overall risk of developing dementia compared to non-opioid analgesic users. Those on high-potency opioids faced an even greater risk, exceeding 70%. Conversely, individuals taking non-opioid painkillers showed dementia risk comparable to those not using opioids.
Neuroimaging assessments further revealed that regular, strong opioid use was associated with reductions in total brain volume, white matter, and hippocampal size—regions crucial for memory and cognition. Additionally, regular opioid use was linked to decreased fluid intelligence, although no significant decline was observed in prospective memory.
These findings underscore the importance of evaluating opioid potency and cumulative exposure when considering risks related to cognitive decline. The research underscores the necessity for cautious opioid prescribing, especially for long-term pain management, to mitigate potential adverse effects on brain health.
Source: https://medicalxpress.com/news/2025-07-regular-opioid-dementia.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Survey Highlights Unfitness of Police Uniforms in England and Wales and Related Health Concerns
A comprehensive survey uncovers widespread dissatisfaction and health risks associated with police uniforms in England and Wales, emphasizing the need for better ergonomic design to protect officers' wellbeing and effectiveness.
Research Links Air Pollution to Increased Risk of Obesity and Diabetes
New research reveals that long-term exposure to air pollution, particularly PM2.5 particles, can impair brown fat function through epigenetic changes, increasing the risk of obesity and diabetes. This study highlights environmental pollutants as significant contributors to metabolic health issues and potential targets for future therapies.
Pesticide Rotenone Exposure Alters Brain Gene Activity Linked to Parkinson's Disease
New research reveals that exposure to the pesticide rotenone causes lasting gene expression changes in brain regions linked to Parkinson's disease, shedding light on environmental risk factors and mechanisms of neurodegeneration.
RSV Vaccination During Pregnancy and Its Impact on Perinatal Outcomes and Health Equity
A recent study reveals that RSV vaccination during pregnancy is safe for mothers and infants, but uptake varies widely among different demographic groups, highlighting the need for targeted public health strategies to address disparities.